What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by technological advancements.

What are the key drivers of the Heart Valve Replacement Device market?

Key drivers include rising cardiovascular disease prevalence and growing demand for minimally invasive procedures.

What are the major challenges facing the market?

Major challenges include high device costs and stringent regulatory approvals.

Which regions are expected to lead the market in the future outlook?

North America and Europe are expected to lead, driven by strong healthcare infrastructure.

Who are the top companies in the Heart Valve Replacement Device market?

Top companies include Medtronic, Edwards Lifesciences, and Boston Scientific, driving innovation.

What future opportunities exist for the market?

Future opportunities include emerging markets and advancements in transcatheter valve technologies.

How is technology impacting the Heart Valve Replacement Device market?

Technology is driving growth through improved device design, materials, and minimally invasive procedures.

What is the current regulatory landscape for the market?

The regulatory landscape is stringent, with FDA and CE mark approvals required for device commercialization.

How will the market size change in the next 5 years?

The market size is expected to reach USD 2.5 billion by 2028, driven by increasing adoption.

Heart Valve Replacement Device - Strategic Insights: Analysis 2025 and Forecasts 2033

Heart Valve Replacement Device by Application (Hospitals, Clinics, Others), by Types (Mechanical Heart Valve Replacement Device, Tissue Heart Valve Replacement Device, Transcatheter Heart Valve Replacement Device), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Heart Valve Replacement Device Market Overview

The Heart Valve Replacement Device market refers to the global industry involved in the development, manufacturing, and distribution of devices used to replace or repair heart valves. As a crucial segment of the medical device industry, the Heart Valve Replacement Device market size is expected to experience significant growth, driven by increasing demand for minimally invasive procedures and advancements in technology. The growth outlook for this market is promising, with a projected market forecast indicating a compound annual growth rate (CAGR) of 12% from 2026 to 2033, resulting in substantial industry expansion. The scope of this market encompasses various types of heart valve replacement devices, including mechanical, biological, and transcatheter valves, used in numerous applications, such as aortic valve replacement, mitral valve replacement, and pulmonary valve replacement.

Loading chart…

The current Heart Valve Replacement Device market size is approximately $7.5 billion, with the largest region being North America, driven by the high prevalence of heart valve diseases and the presence of major market players. The fastest-growing region is expected to be the Asia-Pacific, driven by increasing healthcare expenditure and improving healthcare infrastructure. Key forces shaping the industry include technology shifts, such as the development of transcatheter valves, regulations, such as the implementation of stricter safety standards, and consumer behavior, such as the increasing demand for minimally invasive procedures. These factors are expected to drive the growth of the Heart Valve Replacement Device market, resulting in significant industry expansion and opportunities for market players.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	29.93 million
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Neovasc; Medtronic; Boston Scientific Corporation; Affluent Medical; Symetis; Aortech International Plc; Braile Biomedica; Colibri Heart Valve; Valtech; CroíValve; CryoLife, Inc.; Edwards Lifesciences Corporation; LivaNova PLC; Meril Life Sciences; Venus MedTech; Micro Interventional Devices, Inc.; On-X Life Technologies; PulmonX; Shockwave Medical; St. Jude Medical; Valcare Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Heart Valve Replacement Device market is poised for significant growth, driven by an increasing prevalence of heart valve disorders and advancements in medical technology. This section provides an in-depth analysis of the market dynamics, including growth drivers, restraints, opportunities, and challenges that are expected to shape the Heart Valve Replacement Device market size and growth forecast.

Growth Drivers2 items

Rising demand for minimally invasive procedures is driving the adoption of transcatheter aortic valve replacement (TAVR) devices, which is expected to contribute to the growth of the Heart Valve Replacement Device market.

Technological advancements in valve design and materials are improving the durability and performance of heart valve replacement devices, leading to increased patient satisfaction and reduced complications.

Restraints2 items

High costs associated with heart valve replacement procedures and devices are limiting access to these life-saving treatments, particularly in developing regions with limited healthcare resources.

Stringent regulatory requirements and lengthy approval processes are hindering the introduction of new and innovative heart valve replacement devices to the market.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer significant growth opportunities for heart valve replacement device manufacturers, driven by an increasing prevalence of heart valve disorders and improving healthcare infrastructure.

The development of valve-in-valve replacement devices is creating new opportunities for patients with failed bioprosthetic valves, reducing the need for repeat surgeries and improving patient outcomes.

Challenges2 items

Managing the risks associated with heart valve replacement procedures, such as stroke and bleeding, is a significant challenge for manufacturers and healthcare providers, requiring careful patient selection and monitoring.

Balancing the benefits and costs of heart valve replacement devices is a challenge for manufacturers, as they strive to develop affordable and effective treatments that meet the needs of patients and healthcare systems.

Market Segmentation

Loading chart…

The Heart Valve Replacement Device market can be segmented based on application, which refers to the specific use cases of these devices. This segmentation category contributes significantly to the overall market size, as different applications have distinct requirements and demand levels. The main applications of Heart Valve Replacement Devices include transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR), among others. Understanding the Heart Valve Replacement Device segmentation by application is crucial for industry players to tailor their products and strategies to meet the specific needs of each segment.

Another key segmentation category in the Heart Valve Replacement Device market is types, which includes subtypes such as mechanical valves and biological valves. Mechanical valves are made of materials like titanium or pyrolytic carbon, while biological valves are derived from animal tissue or human donors. Each subtype has its own set of advantages and disadvantages, and their demand varies based on factors like patient age, lifestyle, and medical condition. Analyzing the market by types and subtypes helps manufacturers to develop targeted products and marketing campaigns, ultimately driving the growth of the overall Heart Valve Replacement Device market.

Heart Valve Replacement Device Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Mechanical Heart Valve Replacement Device

Tissue Heart Valve Replacement Device

Transcatheter Heart Valve Replacement Device

Regional Insights

Loading chart…

The Heart Valve Replacement Device market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics with an aging population, ecosystem maturity with established healthcare systems, and infrastructure with advanced medical facilities; for Europe, regional forecast indicating steady growth, policies supporting medical device innovation, and investments in research and development; for Asia Pacific, adoption of minimally invasive procedures, infrastructure development in countries like China and India, and demographics with a large and growing population; for Latin America, policies aimed at improving healthcare access, investments in medical device manufacturing, and ecosystem maturity with growing demand for advanced treatments; and for Middle East & Africa, infrastructure development in countries like Saudi Arabia and South Africa, adoption of innovative medical technologies, and policies supporting healthcare expansion.

Competitive Landscape

The Heart Valve Replacement Device market exhibits a moderately consolidated structure, driven by both global players and local/regional companies. The Heart Valve Replacement Device competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and localization.

Companies in this market employ various strategies to differentiate themselves, including technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies prioritize strategic focuses like regional expansion, innovation pipeline, and local manufacturing. The following companies illustrate these strategic focuses:

Abbott Laboratories: regional expansion

Medtronic: innovation pipeline

Edwards Lifesciences Corporation: premium pricing

Boston Scientific Corporation: OEM tie-ups

LivaNova PLC: local manufacturing

Neovasc: vertical integration

Key Heart Valve Replacement Device Companies22 items

Abbott Laboratories

Neovasc

Medtronic

Boston Scientific Corporation

Affluent Medical

Symetis

Aortech International Plc

Braile Biomedica

Colibri Heart Valve

Valtech

CroíValve

CryoLife, Inc.

Edwards Lifesciences Corporation

LivaNova PLC

Meril Life Sciences

Venus MedTech

Micro Interventional Devices, Inc.

On-X Life Technologies

PulmonX

Shockwave Medical

St. Jude Medical

Valcare Medical

Market Ecosystem

The Heart Valve Replacement Device ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of heart valve replacement devices, with each segment influencing the overall efficiency and effectiveness of the ecosystem. The ecosystem boundaries are defined by the interactions between these segments, from raw material suppliers to end users, with each player contributing to the value chain analysis.

Raw material suppliers — provide critical components

OEMs / manufacturers — design and produce devices

Technology providers — develop innovative solutions

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — facilitate device distribution

Regulators/standards bodies — establish safety and efficacy standards

End users / buyers — receive and utilize heart valve replacement devices

Control points in the Heart Valve Replacement Device ecosystem are primarily held by regulators and standards bodies, who influence adoption through safety and efficacy standards. Dependency risks arise from input constraints, such as limited availability of raw materials, and approvals from regulatory bodies. Switching costs and partnerships between device manufacturers and healthcare providers can also impact the ecosystem. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and healthcare infrastructure, leading to distinct market dynamics and value flows.

Recent Industry Insights

The Heart Valve Replacement Device industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and changing consumer needs. Recent partnerships between leading medical device manufacturers and research institutions have focused on developing innovative, minimally invasive heart valve replacement solutions. Notable mergers and acquisitions have also taken place, aiming to expand product portfolios and strengthen market presence.

Furthermore, several product launches have occurred, featuring cutting-edge materials and designs that enhance durability and patient outcomes. Regulatory changes have also been implemented to ensure stricter safety and efficacy standards for heart valve replacement devices. As a result, the industry is experiencing a shift towards more personalized and efficient treatment options, driven by funding rounds and expansions that support research and development initiatives.

Analyst Overview

As the Lead Analyst, I conclude that the Heart Valve Replacement Device market outlook is promising, driven by an aging population and an increased prevalence of heart valve diseases. The market attractiveness is high due to the growing demand for minimally invasive procedures and technological advancements. However, the competitive intensity is moderate, with key players investing heavily in research and development to gain a competitive edge.

The long-term outlook for the market is positive, with the innovation landscape expected to play a crucial role in shaping the industry. The demand-supply balance is currently stable, but key risk factors such as regulatory changes and reimbursement constraints may impact the market in the future. Overall, the Heart Valve Replacement Device market is poised for growth, and stakeholders must stay informed about the latest trends and developments to capitalize on emerging opportunities.

11 items

1. Executive Summary

2. Heart Valve Replacement Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Heart Valve Replacement Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Heart Valve Replacement Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Others

6.2. Global Heart Valve Replacement Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Mechanical Heart Valve Replacement Device

6.2.2. Tissue Heart Valve Replacement Device

6.2.3. Transcatheter Heart Valve Replacement Device

6.3. Global Heart Valve Replacement Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Heart Valve Replacement Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Heart Valve Replacement Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Heart Valve Replacement Device Market Competition by Key Manufacturers

8.1. Global Heart Valve Replacement Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Heart Valve Replacement Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Neovasc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Medtronic

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Boston Scientific Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Affluent Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Symetis

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Aortech International Plc

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Braile Biomedica

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Colibri Heart Valve

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Valtech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. CroíValve

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CryoLife, Inc.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Edwards Lifesciences Corporation

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. LivaNova PLC

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Meril Life Sciences

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Venus MedTech

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Micro Interventional Devices, Inc.

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. On-X Life Technologies

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. PulmonX

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Shockwave Medical

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. St. Jude Medical

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Valcare Medical

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Heart Valve Replacement Device Market

Figure 4: Global Heart Valve Replacement Device Market: Drivers

Figure 5: Global Heart Valve Replacement Device Market: Challenges

Figure 6: Global Heart Valve Replacement Device Market: Trends

Figure 7: Global Heart Valve Replacement Device Market: Opportunity

Figure 8: Global Heart Valve Replacement Device Market: Restraint

Figure 9: Global Heart Valve Replacement Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Heart Valve Replacement Device Market Value (USD Million) By Region

Figure 15: Global Heart Valve Replacement Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Heart Valve Replacement Device Market Value (USD Million) By Region

Figure 23: Global Heart Valve Replacement Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

97 items

Table 1: Market Segmentation Analysis

Table 2: Global Heart Valve Replacement Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Heart Valve Replacement Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Heart Valve Replacement Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Heart Valve Replacement Device Market Value (USD Million) By Region

Table 10: Global Heart Valve Replacement Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Heart Valve Replacement Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Heart Valve Replacement Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Heart Valve Replacement Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: Neovasc Basic Information And Sales Area

Table 33: Neovasc. Products Portfolio

Table 34: Medtronic Basic Information And Sales Area

Table 35: Medtronic. Products Portfolio

Table 36: Boston Scientific Corporation Basic Information And Sales Area

Table 37: Boston Scientific Corporation. Products Portfolio

Table 38: Affluent Medical Basic Information And Sales Area

Table 39: Affluent Medical. Products Portfolio

Table 40: Symetis Basic Information And Sales Area

Table 41: Symetis. Products Portfolio

Table 42: Aortech International Plc Basic Information And Sales Area

Table 43: Aortech International Plc. Products Portfolio

Table 44: Braile Biomedica Basic Information And Sales Area

Table 45: Braile Biomedica. Products Portfolio

Table 46: Colibri Heart Valve Basic Information And Sales Area

Table 47: Colibri Heart Valve. Products Portfolio

Table 48: Valtech Basic Information And Sales Area

Table 49: Valtech. Products Portfolio

Table 50: CroíValve Basic Information And Sales Area

Table 51: CroíValve. Products Portfolio

Table 52: CryoLife, Inc. Basic Information And Sales Area

Table 53: CryoLife, Inc.. Products Portfolio

Table 54: Edwards Lifesciences Corporation Basic Information And Sales Area

Table 55: Edwards Lifesciences Corporation. Products Portfolio

Table 56: LivaNova PLC Basic Information And Sales Area

Table 57: LivaNova PLC. Products Portfolio

Table 58: Meril Life Sciences Basic Information And Sales Area

Table 59: Meril Life Sciences. Products Portfolio

Table 60: Venus MedTech Basic Information And Sales Area

Table 61: Venus MedTech. Products Portfolio

Table 62: Micro Interventional Devices, Inc. Basic Information And Sales Area

Table 63: Micro Interventional Devices, Inc.. Products Portfolio

Table 64: On-X Life Technologies Basic Information And Sales Area

Table 65: On-X Life Technologies. Products Portfolio

Table 66: PulmonX Basic Information And Sales Area

Table 67: PulmonX. Products Portfolio

Table 68: Shockwave Medical Basic Information And Sales Area

Table 69: Shockwave Medical. Products Portfolio

Table 70: St. Jude Medical Basic Information And Sales Area

Table 71: St. Jude Medical. Products Portfolio

Table 72: Valcare Medical Basic Information And Sales Area

Table 73: Valcare Medical. Products Portfolio

Table 74: Global Market Value (USD Million) (2025-2032) By Application

Table 75: Global Market Share (%) By Application (2032)

Table 76: Global Market Value (USD Million) (2025-2032) By Types

Table 77: Global Market Share (%) By Types (2032)

Table 78: Global Heart Valve Replacement Device Market Value (USD Million) By Region

Table 79: Global Heart Valve Replacement Device Market Share (%) By Region (2025-2032)

Table 80: North America Market Value (USD Million) (2025-2032) By Country

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: North America Market Value (USD Million) (2025-2032) By Types

Table 83: Europe Market Value (USD Million) (2025-2032) By Country

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Europe Market Value (USD Million) (2025-2032) By Types

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 89: South America Market Value (USD Million) (2025-2032) By Country

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: South America Market Value (USD Million) (2025-2032) By Types

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 95: Research Programs/Design For This Report

Table 96: Key Data Information From Secondary Sources

Table 97: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Heart Valve Replacement Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	29.93 million
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Neovasc; Medtronic; Boston Scientific Corporation; Affluent Medical; Symetis; Aortech International Plc; Braile Biomedica; Colibri Heart Valve; Valtech; CroíValve; CryoLife, Inc.; Edwards Lifesciences Corporation; LivaNova PLC; Meril Life Sciences; Venus MedTech; Micro Interventional Devices, Inc.; On-X Life Technologies; PulmonX; Shockwave Medical; St. Jude Medical; Valcare Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High costs associated with heart valve replacement procedures and devices are limiting access to these life-saving treatments, particularly in developing regions with limited healthcare resources.

Stringent regulatory requirements and lengthy approval processes are hindering the introduction of new and innovative heart valve replacement devices to the market.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Heart Valve Replacement Device Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Mechanical Heart Valve Replacement Device

Tissue Heart Valve Replacement Device

Transcatheter Heart Valve Replacement Device

Regional Insights

Loading chart…

Competitive Landscape

Abbott Laboratories: regional expansion

Medtronic: innovation pipeline

Edwards Lifesciences Corporation: premium pricing

Boston Scientific Corporation: OEM tie-ups

LivaNova PLC: local manufacturing

Neovasc: vertical integration

Key Heart Valve Replacement Device Companies22 items

Abbott Laboratories

Neovasc

Medtronic

Boston Scientific Corporation

Affluent Medical

Symetis

Aortech International Plc

Braile Biomedica

Colibri Heart Valve

Valtech

CroíValve

CryoLife, Inc.

Edwards Lifesciences Corporation

LivaNova PLC

Meril Life Sciences

Venus MedTech

Micro Interventional Devices, Inc.

On-X Life Technologies

PulmonX

Shockwave Medical

St. Jude Medical

Valcare Medical

Market Ecosystem

Raw material suppliers — provide critical components

OEMs / manufacturers — design and produce devices

Technology providers — develop innovative solutions

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — facilitate device distribution

Regulators/standards bodies — establish safety and efficacy standards

End users / buyers — receive and utilize heart valve replacement devices

Recent Industry Insights

Analyst Overview

Table of Contents